Functional Dyspepsia Clinical Trial
Official title:
Assessment of Gastric Motor and Sensory Function to a Large Test Meal by Gamma Scintigraphy, Magnetic Resonance Imaging and a Nutrient Drink Test in Health and Patients With Functional Dyspepsia
Dyspeptic symptoms such as abdominal pain, bloating and nausea after a meal are common;
however the cause of these problems in many patients is often unclear despite medical
investigation. This is because "dyspeptic symptoms" are only rarely related to acid reflux,
stomach ulcers or cancer that can be diagnosed by endoscopy. Rather, the cause is abnormal
stomach function, so-called "functional dyspepsia", a condition in which the digestive
system does not function normally after a meal. Gastric scintigraphy is the standard
investigation of stomach function in patients with this condition. It involves eating a
small test meal that includes a tiny dose of radioactive material so that the movement of
food can be visualised as it empties from the stomach. An important limitation of this
approach is that symptoms are rarely caused and delayed emptying after a small meal is
present only in a minority of patients and, thus, the ability of this investigation to
explain the cause of symptoms or guide medical treatment is limited.
This research project is designed to compare three new investigations of stomach function
using a relatively large meal. This information will help to explain the causes of symptoms
after a meal. The investigations to be tested include: (1) Nutrient Drink Test, (2) Gastric
Scintigraphy and (3) Magnetic Resonance Imaging. All three tests are safe, easy to perform
and non-invasive (i.e. do not involve inserting catheters through the nose and into the
stomach or taking blood). The results should provide more useful information to doctors
looking after patients with dyspeptic symptoms.
This study will compare test results from healthy volunteers, with patients attending clinic
for investigation of dyspeptic symptoms. The aim is to document abnormal function of the
stomach and intestines and to identify the causes of dyspeptic symptoms after a meal.
The Nutrient Drinking Test will be performed as part of the screening visit to ensure that
all patients that consent to participate in the full study are able to complete the imaging
studies that require ingestion of 400ml liquid nutrient (Fortisip Vanilla (Nutricia
Clinical) diluted 1:1 with water to 0.75kcal/ml, 4.5g fat/100ml).
Subjects will drink one from a series of beakers containing 40ml liquid nutrient every
minute. During the drinking test, subjects will score satiety, fullness, bloating,
heartburn, nausea and epigastric pain at 5-min intervals using a 100mm visual analogue scale
(sample attached). Participants will be instructed to cease intake when they reported
maximal satiety or very severe dyspeptic symptoms (defined as VAS score of >90 mm). The
total volume ingested will be recorded. Symptoms will be assessed again 15 and 30 min after
cessation of intake.
If the subject fulfils the inclusion and exclusion criteria including ingestion of ≥400ml at
the drinking test and consents to continue then appointments will be made for gamma
scintigraphy and MRI studies according to a prospective randomization plan.
MRI Study Day After eligibility has been confirmed subjects will ingest the paramagnetic
contrast labelled liquid nutrient test meal according to a standardized protocol. Subjects
will drink one from a series of ten beakers containing 40ml liquid nutrient every minute.
During the test meal, subjects will score satiety, fullness, bloating, heartburn, nausea and
epigastric pain at baseline, 5 and 10 minute using a visual analogue scale (VAS 0-100 mm).
These measurements will be repeated at 30min and at the conclusion of the imaging study (see
below).
Studies will be performed using a 1.5T whole MRI system (Intera, Philips, Best, The
Netherlands). Six rectangular surface coils (height = 20 cm, width = 10 cm), fixed around
the abdomen and connected to independent receive channels were used for signal detection.
Gamma Scintigraphy Study Day After eligibility has been confirmed subjects will ingest the
radiolabelled liquid nutrient test meal according to a standardized protocol. Subjects will
drink one from a series of ten beakers containing 40ml liquid nutrient every minute. During
the test meal, subjects will score satiety, fullness, bloating, heartburn, nausea and
epigastric pain at baseline, 5 and 10 min using a visual analogue scale (VAS 0-100 mm).
;
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04656730 -
Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas
|
Phase 4 | |
Completed |
NCT04464369 -
Functional Dyspepsia: Validation of the Leuven Postprandial Distress Scale (LPDS) in a Placebo-controlled Trial
|
Phase 4 | |
Completed |
NCT01671670 -
Acupuncture for Patients With Function Dyspepsia
|
Phase 2/Phase 3 | |
Completed |
NCT00987805 -
Efficacy of Banhasasim-tang on Functional Dyspepsia
|
Phase 4 | |
Completed |
NCT00761358 -
To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia
|
Phase 3 | |
Completed |
NCT00693407 -
Study of Endogenous Inhibitory Modulation During Gastric and Somatic Stimulation
|
N/A | |
Recruiting |
NCT01240096 -
Mirtazapine Versus Placebo in Functional Dyspepsia
|
Phase 4 | |
Recruiting |
NCT04540549 -
Effects of Exercise on Functional Dyspepsia Based on Rome IV
|
N/A | |
Recruiting |
NCT03652571 -
Nortriptyline for the Treatment of Functional Dyspepsia
|
Phase 3 | |
Recruiting |
NCT06068114 -
Gastric Pathophysiology in Diabetes
|
||
Recruiting |
NCT03825692 -
International Clinical Study of Zhizhu Kuanzhong Capsule
|
Phase 4 | |
Not yet recruiting |
NCT04548011 -
Acupuncture of Different Treatment Frequency on Improving Quality of Life in Patients With Functional Dyspepsia
|
N/A | |
Terminated |
NCT02567578 -
A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia
|
Phase 2 | |
Active, not recruiting |
NCT00990405 -
Clinical Study to Evaluate the Efficacy and the Safety of Eradication Therapy for Helicobacter Pylori in Functional Dyspepsia
|
Phase 4 | |
Completed |
NCT00404534 -
Helicobacter Eradication Relief of Dyspeptic Symptoms
|
Phase 3 | |
Completed |
NCT03043625 -
Visceral Manipulation Treatment to Patients With Non-specific Neck Pain With Functional Dyspepsia
|
N/A | |
Completed |
NCT03225248 -
Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia
|
Phase 3 | |
Recruiting |
NCT05587127 -
Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia
|
N/A | |
Recruiting |
NCT01021475 -
Does Visceral Manipulation Works in Treating Functional Dyspepsia?
|
Phase 1 | |
Completed |
NCT00599677 -
Randomized Controlled Trial of Acupuncture for Functional Dyspepsia
|
N/A |